BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $762,000 | -20.5% | 11,583 | -6.8% | 0.02% | +8.7% |
| Q3 2018 | $958,000 | +3.6% | 12,433 | -0.8% | 0.02% | -4.2% |
| Q2 2018 | $925,000 | +12.5% | 12,533 | -0.8% | 0.02% | 0.0% |
| Q1 2018 | $822,000 | -5.0% | 12,633 | -5.6% | 0.02% | -4.0% |
| Q4 2017 | $865,000 | +4.6% | 13,382 | +1.6% | 0.02% | +4.2% |
| Q3 2017 | $827,000 | +2.1% | 13,172 | -1.5% | 0.02% | -11.1% |
| Q2 2017 | $810,000 | +13.0% | 13,372 | -3.3% | 0.03% | +17.4% |
| Q1 2017 | $717,000 | +16.2% | 13,822 | -0.7% | 0.02% | +15.0% |
| Q4 2016 | $617,000 | -8.2% | 13,922 | -1.4% | 0.02% | +5.3% |
| Q3 2016 | $672,000 | +5.2% | 14,122 | 0.0% | 0.02% | +18.8% |
| Q2 2016 | $639,000 | +10.2% | 14,122 | 0.0% | 0.02% | +14.3% |
| Q1 2016 | $580,000 | +8.4% | 14,122 | +0.7% | 0.01% | +16.7% |
| Q4 2015 | $535,000 | +16.6% | 14,022 | +0.4% | 0.01% | +50.0% |
| Q3 2015 | $459,000 | -49.6% | 13,972 | +7.3% | 0.01% | -38.5% |
| Q2 2015 | $911,000 | +28.1% | 13,022 | +25.5% | 0.01% | +30.0% |
| Q1 2015 | $711,000 | -5.6% | 10,372 | +1.0% | 0.01% | 0.0% |
| Q4 2014 | $753,000 | +7.9% | 10,272 | +5.7% | 0.01% | +11.1% |
| Q3 2014 | $698,000 | -0.7% | 9,722 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $703,000 | +123.9% | 9,722 | +127.6% | 0.01% | +125.0% |
| Q1 2014 | $314,000 | +5.7% | 4,272 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $297,000 | +5.7% | 4,272 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $281,000 | -5.1% | 4,272 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $296,000 | – | 4,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |